Company Filing History:
2 out of 1,745 
2 out of 5,094 
2 out of 54 
Years Active: 2016-2017
Title: Anne Rogel: Innovator in Melanoma Research
Introduction
Anne Rogel is a prominent inventor based in Nantes, France. She has made significant contributions to the field of melanoma research, particularly through her innovative peptide inventions. With a total of 2 patents, her work focuses on the prevention and treatment of melanoma, a serious form of skin cancer.
Latest Patents
Rogel's latest patents include groundbreaking inventions related to melanoma antigen peptides. The first patent describes a melanoma antigen peptide comprising specific amino acid sequences, which are crucial for developing treatments for melanoma patients. The second patent also focuses on a melanoma antigen peptide with a different set of amino acid sequences, emphasizing its potential use in preventing and treating melanoma.
Career Highlights
Throughout her career, Anne Rogel has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Rogel has collaborated with notable colleagues, including Nathalie Labarriere and Mathilde Bobinet. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Anne Rogel's innovative work in melanoma research highlights her dedication to improving patient outcomes through scientific advancements. Her contributions continue to pave the way for new treatments in the fight against melanoma.